Normoxic accumulation of HIF1α is associated with glutaminolysis

Clinical Oral Investigations

Volumn 21, Issue 1, 2017, Pages 211-224

  Kappler, Matthias ^a   Pabst, Ulrike ^a   Rot, Swetlana ^a   Taubert, Helge ^b   Wichmann, Henri ^a   Schubert, Johannes ^a   Bache, Matthias ^a   Weinholdt, Claus ^a   Immel, Uta Dorothee ^a   Grosse, Ivo ^a   Vordermark, Dirk ^a   Eckert, Alexander W ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Ammonia; Ammonium; Glutamine; Glutaminolysis; HIF1 ; Metabolism; Normoxia; Warburg effect

Indexed keywords

AMMONIA; CARBONATE DEHYDRATASE IX; GLUTAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

CELL PROLIFERATION; DRUG EFFECTS; HUMAN; HYPOXIA; METABOLISM; POLYMERASE CHAIN REACTION; RNA PROCESSING; TUMOR CELL LINE; WESTERN BLOTTING;

AMMONIA; BLOTTING, WESTERN; CARBONIC ANHYDRASE IX; CELL LINE, TUMOR; CELL PROLIFERATION; GLUTAMINE; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 84960128702     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-016-1780-9     Document Type: Article

References (68)

1. Semenza GL (2009) Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19(1):12–16. doi:10.1016/j.semcancer.2008.11.009
2. Semenza GL (2010) HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20(1):51–56. doi:10.1016/j.gde.2009.10.009
3. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033. doi:10.1126/science.1160809
4. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5):325–337. doi:10.1038/nrc3038
5. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1):11–20. doi:10.1016/j.cmet.2007.10.002
6. Miller AL (1999) Therapeutic considerations of L-glutamine: a review of the literature. Altern Med Rev 4(4):239–248
7. Dang CV (2010) Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 9(19):3884–3886. doi:10.4161/cc.9.19.13302
8. Dang CV, Hamaker M, Sun P, et al. (2011) Therapeutic targeting of cancer cell metabolism. J Mol Med 89(3):205–212. doi:10.1007/s00109-011-0730-x
9. Dang CV (2010) Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 70(3):859–862. doi:10.1158/0008-5472.CAN-09-3556
10. Smolková K, Bellance N, Scandurra F, et al. (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr 42(1):55–67. doi:10.1007/s10863-009-9267-x
11. Smolková K, Plecitá-Hlavatá L, Bellance N, et al. (2011) Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol 43(7):950–968. doi:10.1016/j.biocel.2010.05.003
12. Fendt S, Bell EL, Keibler MA, et al. (2013) Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells. Nat Commun 4:2236. doi:10.1038/ncomms3236
13. Epstein AC, Gleadle JM, McNeill LA, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation//C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1):43–54. doi:10.1016/S0092-8674(01)00507-4
14. Ivan M, Kondo K, Yang H, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292(5516):464–468. doi:10.1126/science.1059817
15. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721–732. doi:10.1038/nrc1187
16. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148(3):399–408. doi:10.1016/j.cell.2012.01.021
17. Kappler M, Taubert H, Holzhausen H, et al. (2008) Immunohistochemical detection of HIF-1α and CAIX in advanced head-and-neck cancer. Strahlenther Onkol 184(8):393–399. doi:10.1007/s00066-008-1813-7
18. Bache M, Kappler M, Said HM, et al. (2008) Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Curr Med Chem 15(4):322–338. doi:10.2174/092986708783497391#sthash.igXXfwmp.dpuf
19. Eckert AW, Lautner MHW, Schütze A, et al. (2010) Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients. J Oral Pathol Med 39(4):313–317. doi:10.1111/j.1600-0714.2009.00829.x
20. Eckert AW, Lautner MHW, Schütze A, et al. (2011) Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology 58(7):1136–1147. doi:10.1111/j.1365-2559.2011.03806.x
21. Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26(2):225–239. doi:10.1007/s10555-007-9055-1
22. Zhang H, Bosch-Marce M, Shimoda LA, et al. (2008) Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283(16):10892–10903. doi:10.1074/jbc.M800102200
23. Koivunen P, Hirsilä M, Remes AM, et al. (2007) Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 282(7):4524–4532. doi:10.1074/jbc.M610415200
24. King A, Selak MA, Gottlieb E (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25(34):4675–4682. doi:10.1038/sj.onc.1209594
25. Ashrafian H, O’Flaherty L, Adam J, et al. (2010) Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis. Cancer Res 70(22):9153–9165. doi:10.1158/0008-5472.CAN-10-1949
26. Kwon SJ, Lee YJ (2005) Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin Cancer Res 11(13):4694–4700. doi:10.1158/1078-0432.CCR-04-2530
27. Vordermark D, Kraft P, Katzer A, et al. (2005) Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett 230(1):122–133. doi:10.1016/j.canlet.2004.12.040
28. Zundel W, Schindler C, Haas-Kogan D, et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14(4):391–396
29. Peng X, Karna P, Cao Z, et al. (2006) Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281(36):25903–25914. doi:10.1074/jbc.M603414200
30. Wang L, Zhou W, Gou S, et al. (2010) Insulin promotes proliferative vitality and invasive capability of pancreatic cancer cells via hypoxia-inducible factor 1alpha pathway. J Huazhong Univ Sci Technol Med Sci 30(3):349–353. doi:10.1007/s11596-010-0355-2
31. Blancher C, Moore JW, Robertson N, et al. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res 61(19):7349–7355
32. Dayan F, Bilton RL, Laferrière J, et al. (2009) Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway. J Cell Physiol 218(1):167–174. doi:10.1002/jcp.21584
33. Mayer A, Höckel M, Vaupel P (2008) Endogenous hypoxia markers: case not proven! Adv Exp Med Biol 614(614):127–136. doi:10.1007/978-0-387-74911-2_15
34. Hernandez VJ, Weng J, Ly P, et al. (2013) Cavin-3 dictates the balance between ERK and Akt signaling. Elife 2:e00905. doi:10.7554/elife.00905
35. Parks SK, Chiche J, Pouysségur J (2013) Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 13(9):611–623. doi:10.1038/nrc3579
36. Kappler M, Taubert H, Eckert AW (2011) Oxygen sensing, homeostasis, and disease. N Engl J Med (365):1845–1846. doi:10.1056/NEJMc1110602#SA2
37. Kappler M, Taubert H, Schubert J, et al. (2012) The real face of HIF1α in the tumor process. Cell Cycle 11(21):3932–3936. doi:10.4161/cc.21854
38. Griffiths JR, McSheehy PMJ, Robinson SP, et al. (2002) Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway. Cancer Res 62(3):688–695
39. Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277(26):23111–23115. doi:10.1074/jbc.M202487200
40. Lu H, Dalgard CL, Mohyeldin A, et al. (2005) Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280(51):41928–41939. doi:10.1074/jbc.M508718200
41. Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123(9):3664–3671. doi:10.1172/JCI67230
42. Sun RC, Denko NC (2014) Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab 19(2):285–292. doi:10.1016/j.cmet.2013.11.022
43. Tallis S, Caltana LR, Souto PA, et al. (2014) Changes in CNS cells in hyperammonemic portal hypertensive rats. J Neurochem 128(3):431–444. doi:10.1111/jnc.12458
44. Hobiger G (1996) Ammoniak in Wasser: Ableitung einer Formel zur Berechnung von Ammoniak in wäßrigen Lösungen. Berichte/Umweltbundesamt, Umweltbundesamt, Wien
45. Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8(9):705–713. doi:10.1038/nrc2468
46. DeBerardinis RJ, Mancuso A, Daikhin E, et al. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104(49):19345–19350. doi:10.1073/pnas.0709747104
47. Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92(3):329–333. doi:10.1016/j.radonc.2009.06.025
48. Meng M, Chen S, Lao T, et al. (2010) Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle 9(19):3921–3932. doi:10.4161/cc.9.19.13139
49. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21(3):297–308. doi:10.1016/j.ccr.2012.02.014
50. Demidenko ZN, Blagosklonny MV (2014) The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1α. Cell Cycle 10(10):1557–1562. doi:10.4161/cc.10.10.15789
51. Wise DR, Thompson CB (2010) Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35(8):427–433. doi:10.1016/j.tibs.2010.05.003
52. Shanware NP, Bray K, Eng CH, et al. (2014) Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion. Nat Commun 5:4900. doi:10.1038/ncomms5900
53. Stiehl DP, Jelkmann W, Wenger RH, et al. (2002) Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett 512(1–3):157–162
54. Hernández-Bedolla MA, Carretero-Ortega J, Valadez-Sánchez M, et al. (2015) Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells. Biochim Biophys Acta 1853(1):166–182. doi:10.1016/j.bbamcr.2014.10.011
55. McQueen A, Bailey JE (1990) Effect of ammonium ion and extracellular pH on hybridoma cell metabolism and antibody production. Biotechnol Bioeng 35(11):1067–1077. doi:10.1002/bit.260351102
56. Ferreira TB, Carrondo MJT, Alves PM (2007) Effect of ammonia production on intracellular pH: consequent effect on adenovirus vector production. J Biotechnol 129(3):433–438. doi:10.1016/j.jbiotec.2007.01.010
57. Chiche J, Brahimi-Horn MC, Pouysségur J (2010) Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 14(4):771–794. doi:10.1111/j.1582-4934.2009.00994.x
58. Trivedi B, Danforth WH (1966) Effect of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem 241(17):4110–4112
59. Yu Z, Persson H, Eaton JW, et al. (2003) Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic Biol Med 34(10):1243–1252. doi:10.1016/S0891-5849(03)00109-6
60. Brahimi-Horn MC, Bellot G, Pouysségur J (2011) Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev 21(1):67–72. doi:10.1016/j.gde.2010.10.006
61. Parks SK, Chiche J, Pouyssegur J (2011) pH control mechanisms of tumor survival and growth. J Cell Physiol 226(2):299–308. doi:10.1002/jcp.22400
62. Parks SK, Mazure NM, Counillon L, et al. (2013) Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels. J Cell Physiol 228(9):1854–1862. doi:10.1002/jcp.24346
63. Chiche J, Le Fur Y, Vilmen C, et al. (2012) In vivo pH in metabolic-defective ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int J Cancer 130(7):1511–1520. doi:10.1002/ijc.26125
64. Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 18(5):330–337. doi:10.1016/j.semcancer.2008.03.011
65. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13(6):472–482. doi:10.1016/j.ccr.2008.05.005
66. Warburg O (1956) On respiratory impairment in cancer cells. Science 124(3215):269–270
67. Kappler M, Rot S, Taubert H, et al. (2007) The effects of knockdown of wild-type survivin, survivin-2B or survivin-3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions. Cancer Gene Ther 994–1001. doi:10.1038/sj.cgt.7701090
68. Kappler M, Bache M, Bartel F, et al. (2004) Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther 11(3):186–193. doi:10.1038/sj.cgt.7700677